MICHELLE JENKINS: Open Payments
NPI 1326152695 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 26 payments from 14 companies in 2025. Trend: 2023 $457 · 2024 $417 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $107 |
| Merck Sharp & Dohme LLC | 4 | $106 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Novo Nordisk Inc | 3 | $50 |
| Eisai Inc. | 2 | $50 |
| Astellas Pharma US Inc | 2 | $44 |
| On Target Laboratories, Inc | 1 | $31 |
| ABBVIE INC. | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
Products named: LYNPARZA, KEYTRUDA, JEMPERLI, Ozempic, Lenvima, Veozah, Cytalux, ELAHERE.
Industry payments across GA — which companies pay providers there.
